type here...

CATEGORIES

Press Release

LATEST

1...678...12Page 7 of 12

TRENDING

EDITORS CHOICE

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

Medika Life -
CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

The New Botanical Beverage that Biohacks Your Body Clock

Medika Life -
BioLift was shown through 3 clinical trials to increase productivity, reduce brain fog, and maintain clarity for higher performance. But, unlike its caffeinated competitors, BioLift does not increase pulse or blood pressure

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Renowned Endocrinologist Leon Igel MD, Recognized for Pioneering Work in Diabetes and Obesity Management

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories